Replies to post #401044 on Anavex Life Sciences Corp (AVXL)

[DoTheRightThing]

is exceeds the original enrollment target and the Company expects to announce topline results from this study in 2H 2023.

Why does the company keep doing this? At this point it would be better to just not announce any expected timelines. Just say results pending or something like that. I can't recall them ever hitting on one of these timelines. q2 2024 it is... Another year gone